Further, consistent with the bioluminescence results, intensity scoring of GBM samples stained to detect phospho-rpS6 was reduced, indicating a significant inhibition of S6K signaling (Fig. 1F). This evidence concerns the gene RPS6KB1 and glioblastoma.